Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
How much larger will the Virtual Biopsy Market be in 2030 compared with 2026?
The virtual biopsy market size has experienced significant growth in recent years. This market is projected to expand from $0.71 billion in 2025 to $0.79 billion in 2026, at a compound annual growth rate (CAGR) of 11.9%. The historical expansion of this market can be attributed to several factors, including reliance on traditional biopsy procedures, limited imaging technology capabilities, the increasing prevalence of chronic diseases, a growing hospital and diagnostic infrastructure, and a rising demand for accurate cancer diagnostics.
The virtual biopsy market size is poised for significant expansion over the coming years. By 2030, this market is projected to reach a value of $1.23 billion, demonstrating a compound annual growth rate (CAGR) of 11.7%. The anticipated growth during this period stems from several factors, including developments in imaging algorithms and AI analytics, broader applications in oncology and neurological diagnostics, increased use for cardiovascular and ophthalmological conditions, its incorporation into personalized medicine strategies, and rising funding for research institutions and diagnostic facilities. Key trends foreseen over the forecast horizon encompass a greater embrace of non-invasive diagnostic methods, a heightened need for discovering diseases early, the merging of advanced imaging with predictive analytics, the broadening scope of virtual biopsy uses across diverse therapeutic fields, and an amplified emphasis on patient well-being and quicker recovery.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24424&type=smp
What Drivers Are Guiding Growth Patterns In The Virtual Biopsy Market?
The expanding occurrence of cancer-related conditions is anticipated to fuel the expansion of the virtual biopsy market moving forward. Oncological disorders are health issues tied to cancer, characterized by the uncontrolled proliferation and dissemination of atypical cells within the body. The surge in these conditions primarily stems from lifestyle shifts, including unhealthy eating, lack of physical activity, tobacco consumption, and greater exposure to environmental contaminants. Virtual biopsy aids in detecting and tracking oncological disorders by offering non-invasive, immediate imaging data, thereby diminishing the necessity for conventional tissue biopsies and simultaneously enhancing diagnostic precision and patient well-being. For example, in January 2023, Rock Health, a digital health research entity based in the U.S., reported a projection of 1,958,310 new cancer instances in the U.S. for 2023, marking an increase from approximately 1.9 million new cases recorded in 2022. Consequently, the growing incidence of oncological disorders is propelling the growth of the virtual biopsy market.
Which Segments Are Driving Activity In The Virtual Biopsy Market?
The virtual biopsy market covered in this report is segmented –
1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas
2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds
3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies
4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users
Subsegments:
1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers
2) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions
3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions
4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders
5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions
6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions
7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions
How Are New Market Trends Shaping The Landscape Of The Virtual Biopsy Market?
Leading companies within the virtual biopsy market are concentrating on the development of technologically advanced solutions and the acquisition of necessary approvals, such as for the magnetic resonance spectroscopy (MRS) platform, aiming to improve non-invasive diagnostic accuracy and deliver real-time analysis for the early detection of diseases and personalized treatment. Magnetic resonance spectroscopy (MRS) is a non-invasive imaging technique that aids virtual biopsy by offering comprehensive molecular information about tissues, which allows for precise, real-time identification and monitoring of diseases without requiring invasive procedures. For instance, in November 2023, BrainSpec Inc., a US-based healthtech company, obtained approval from the U.S. Food and Drug Administration (FDA) for its artificial intelligence (AI)-driven BrainSpec platform. This technology employs advanced artificial intelligence (AI) analysis of MR spectroscopy data to quantify brain metabolites like 2-hydroxyglutarate, thereby facilitating non-invasive virtual biopsies for diagnosing conditions such as gliomas, Alzheimer’s, and multiple sclerosis. The system integrates effortlessly with standard magnetic resonance imaging (MRI) scanners, automates data processing, and produces results within minutes. It further utilizes a reference database of brain chemistry to enhance diagnostic precision.
Which Key Market Players Are Investing In Expansion And Innovation Within The Virtual Biopsy Market?
Major companies operating in the virtual biopsy market are Siemens Healthineers AG, GE Healthcare, Canon Medical Systems, Philips Healthcare, Fujifilm Healthcare, Esaote SpA, Samsung Medison, Perspectum Ltd, QUIBIM SL, ImageBiopsy Lab GmbH, Deep Bio Inc, BrainSpec Inc, Oncoustics Inc, AI Metrics LLC, Zebra Medical Vision, Arterys Inc, Aidoc Medical, Viz ai, Subtle Medical, Gleamer AI
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report
Which Geographic Areas Are Emerging As Strong Markets For The Virtual Biopsy Market?
North America was the largest region in the virtual biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Virtual Biopsy Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24424&type=smp
Browse Through More Reports Similar to the Global Virtual Biopsy Market 2026, By The Business Research Company
Virtual Clinical Trials Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report
Biopsy Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Biopsy Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company